Y. Pointreau

Discipline

Economies et finances (2)

Type de document

Articles (3)

Co-auteur

Source

Mot-clé

thérapie (2) risque (2) maladie (2) Treatment (2) Chemotherapy (2) Death (2) Therapeutics (2) Risk (2) Radiotherapy (2) Patients (2) Neck (2) Months (2) Human beings (2) Head (2) Death (2) Chemotherapy (2) Cancer (2) Use (2) Patients (2) Radiotherapy (2) mort (2) maladie (2) ventilation (1) tumeur (1) sécurité (1) épuration (1) oncologie (1) mortalité (1) infection (1) danger (1)

Documents écrit par Y. Pointreau (3) | parle de Y. Pointreau (0)

Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial.
Y. Tao et al.
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
A. Lièvre et al.
PO-120: Head and neck cancers are associated with poor EQ-5D-related utility in France (EPICORL study)
M. Schwarzinger et al.